Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James R. Kasinger currently holds 95,857 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Kasinger has been a net seller of CRSP stock. They have purchased $0 and sold $7.2M worth of shares.
James R. Kasinger's most recent insider trade was on Oct 14, 2026, when they sold 1,040 shares at $49.26 per share.
James R. Kasinger serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 57 insider transactions totaling $7.2M over their tenure at the company.
James R. Kasinger holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
James R. Kasinger has shown a selling trading pattern, with $0 in total purchases and $7.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James R. Kasinger was on Sep 22, 2026, when they sold $626.5K worth of CRSP shares. This transaction involved 10,400 shares at $60.24 per share.
James R. Kasinger currently owns 95,857 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James R. Kasinger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James R. Kasinger has 57 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for James R. Kasinger and 40,000+ other insiders.